Skip to main content
. Author manuscript; available in PMC: 2008 Feb 1.
Published in final edited form as: Immunol Allergy Clin North Am. 2007 Feb;27(1):105–127. doi: 10.1016/j.iac.2006.11.006

Fig. 3.

Fig. 3

Persistent protection against peanut-induced anaphylactic reactions by HKE-MP 123. Mice were challenged at 10 weeks after the last HKE-MP 123 treatment. A. Anaphylactic symptom scores were determined 30 minutes after challenge. Each point indicates an individual mouse. Bars indicate the median of 4 mice in each group. B. Histamine plasma levels were measured in blood samples obtained 30 to 40 minutes after the challenge. Data are means +SEM for each group of 4 mice. *P<0.05, and **P<0.01 versus sham. (Re-printed with permission from Li XM, Srivastava K, Grishin A, Huang CK, Schofield B, Burks W et al. Persistent protective effect of heat-killed Escherichia coli producing “engineered,” recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 2003; 112(1):159–167, with permission from American Academy of Allergy, Asthma and Immunology)